Expression profiles of lipid metabolism-related genes in liver of apoE -/-/LDLR-/- mice

Chinese Journal of Pathology

Volumn 36, Issue 11, 2007, Pages 751-755

  Du, Hui Qin ^a   Yin, Miao ^b   Ye, Hong Yan ^b   Shang, Yun Ju ^b   Dai, Xue Dong ^b   Jing, Wen ^b   Zhang, Liang ^b   Xiao, Ning ^b   Li, Ji Feng ^b   Pan, Jie ^b  

^a SHANDONG NORMAL UNIVERSITY   (China)

^b NONE

Author keywords

Animals, laboratory; Apolipoproteins; Atherosclerosis

Indexed keywords

ACYL COENZYME A OXIDASE; ANGIOPOIETIN; ANGIOPOIETIN 3; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN B100; APOLIPOPROTEIN E; APOLIPOPROTEIN F; CARNITINE PALMITOYLTRANSFERASE; CHOLESTEROL; FATTY ACID TRANSPORTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; LIPID METABOLISM; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD36; AORTA; APOLIPOPROTEIN B-100; APOLIPOPROTEINS; APOLIPOPROTEINS A; APOLIPOPROTEINS E; ATHEROSCLEROSIS; GENE EXPRESSION; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, LDL; RNA, MESSENGER;

EID: 36348988474     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Zhang SH, Reddick RL, Piedrahita JA, et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science,1992,258(16):468-471.
2. Ishibashi S, Herz J, Maeda N, et al. The two-receptor model of lipoprotein clearance; tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Nad Acad Sci USA, 1994, 91(10):4431-4435.
3. Chinese source
4. Pennacchio LA, Rubin EM. Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice. Arterioscler Thromb Vasc Biol, 2003, 23(4):529-534.
5. Merkel M, Loeffler B, Kluger M, et al. Apo1ipoprotein A V accelerates plasma hydrolysis of triglyceride rich lipoproteinsby interaction with proteoglycan hound lipoprotein lipase. J Biol Chem,2005,280(22):21553-21560.
6. Grosskopf I, Baroukh N, Lee SJ, et al. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants. Arterioscler Thromb Vasc Biol, 2005, 25 (12): 2573-2579.
7. Costet P, Luo Y, Wang N, et al. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/ retinoid X receptor. J Biol Chem, 2000, 275 (36):28240-28245.
8. Zhang Y, Repa JJ, Gauthier K, et al. Regulation of lipoprotein lipase by the oxysterol recep tors, LXRα and LXRβ. J Biol Chem, 2001, 276 (46):43018-43024.
9. Laffitte BA, Repa JJ, Joseph SB, et al. LXRs control lipidinducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci U S A, 2001, 98 (2):507-512.
10. Qin X, Swertfeger DK, Zheng S, et al. Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am J Physiol, 1998, 274(5pt2):H1836-H1840.
11. Warner MM, Guo JX, Zhao YM. The relationship between plasma apolipoprotein A IV and coronary heart disease. Chin Med J (Engl),2001,114(3): 275-279.
12. Larsson SL, Skogsberg J, Björkegren J. The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver. J Biol Chem, 2004, 279(2):831-836.